Tarsus Pharmaceuticals Inc (TARS)
20.36 x 2 59.81 x 5
Pre-market by (Cboe BZX)
50.90 +1.18 (+2.37%) 04/29/25 [NASDAQ]
20.36 x 2 59.81 x 5
Pre-market 50.18 -0.72 (-1.41%) 04:10 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | TARS | BLTE | JANX | ||
| Company | Tarsus Pharmaceuticals Inc | Belite Bio Inc ADR | Janux Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 50.02 | 58.68 | 32.09 | ||
| High | 51.24 | 62.75 | 32.69 | ||
| Low | 49.03 | 58.68 | 31.42 | ||
| Last | 50.90 | 62.30 | 32.55 | ||
| Change | +1.18 | +2.12 | +0.32 | ||
| % Change | +2.37% | +3.52% | +0.99% | ||
| Volume | 1,339,200 | 41,000 | 698,400 | ||
| 20-Day Average Volume | 688,290 | 39,835 | 961,540 | ||
| Previous Close | 49.72 | 60.18 | 32.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 48.53 | 58.73 | 28.69 | ||
| 20-Day Raw Stochastic | 89.76% | 78.93% | 98.57% | ||
| 20-Day Relative Strength | 54.94% | 53.36% | 54.44% | ||
| Weighted Alpha | +43.26 | +37.94 | -55.21 | ||
| Today's Opinion | 64% Buy | 40% Buy | 56% Sell | ||
| Previous Opinion | 40% Buy | 8% Sell | 56% Sell | ||
| Last Month's Opinion | 48% Buy | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.95% since 04/22/25 | +6.71% since 04/22/25 | +8.46% since 04/22/25 | ||
| Low | 47.97 on 04/28/25 | 56.00 on 04/23/25 | 30.20 on 04/25/25 | ||
| High | 51.24 on 04/29/25 | 62.75 on 04/29/25 | 32.69 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | -1.62% since 03/28/25 | -6.60% since 03/28/25 | +11.86% since 03/28/25 | ||
| Low | 40.38 on 04/09/25 | 49.00 on 04/09/25 | 22.52 on 04/09/25 | ||
| High | 52.10 on 04/03/25 | 66.76 on 03/31/25 | 32.69 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | -4.09% since 01/29/25 | +8.54% since 01/29/25 | -23.43% since 01/29/25 | ||
| Low | 40.38 on 04/09/25 | 49.00 on 04/09/25 | 22.52 on 04/09/25 | ||
| High | 57.28 on 02/05/25 | 70.99 on 03/13/25 | 46.10 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | +16.02% since 10/29/24 | -10.72% since 10/29/24 | -39.96% since 10/29/24 | ||
| Low | 40.38 on 04/09/25 | 49.00 on 04/09/25 | 22.52 on 04/09/25 | ||
| High | 57.28 on 02/05/25 | 86.53 on 11/14/24 | 71.71 on 12/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,908,104 | 1,916,010 | 1,904,954 | ||
| Shares Outstanding, K | 38,377 | 31,838 | 59,105 | ||
| Annual Sales | 182,950,000 | 0 | 10,590,000 | ||
| Annual Net Income | -115,550,000 | -36,140,000 | -68,990,000 | ||
| Last Quarter Sales | 66,410,000 | 0 | 440,000 | ||
| Last Quarter Net Income | -23,110,000 | -10,100,000 | -28,060,000 | ||
| 60-Month Beta | 0.94 | -1.52 | 3.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 02/25/25 | -0.32 on 03/17/25 | -0.36 on 02/27/25 | ||
| Latest Earnings Date | 05/01/25 | 05/12/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||